Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product

Guido Moll; Norman Drzeniek; Julian Kamhieh-Milz; Sven Geissler; Petra Reinke

doi:10.1111/bjh.16389

Editorial comment: variables affecting the presence of mesenchymal stromal cells in the peripheral blood and their relationship with apheresis product

Br J Haematol. 2020 May;189(4):593-596. doi: 10.1111/bjh.16389. Epub 2020 Feb 10.

Authors

Guido Moll^{1

2}, Norman Drzeniek^{1

2}, Julian Kamhieh-Milz³, Sven Geissler^{1

4}, Petra Reinke^{1

5

6}

Affiliations

¹ BIH Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Berlin, Germany.
² Berlin-Brandenburg School for Regenerative Therapies (BSRT), Charité Universitätsmedizin Berlin, Berlin, Germany.
³ Department of Transfusion Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁴ Julius Wolff Institute (JWI), Charité Universitätsmedizin Berlin, Berlin, Germany.
⁵ Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
⁶ Berlin Center for Advanced Therapies (BECAT), all Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.

PMID: 32037526
DOI: 10.1111/bjh.16389

No abstract available

Keywords: apheresis product; blood circulation; flow cytometry; granulocyte colony-stimulating factor; haematopoietic stem cell transplantation; mesenchymal stromal cells; peripheral blood; stem cell mobilization.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Blood Component Removal*
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cell Mobilization
Humans
Mesenchymal Stem Cells*

Substances

Granulocyte Colony-Stimulating Factor

Publication types

MeSH terms

Substances

Grants and funding